SCHEMBL5284518

SCHEMBL5284518

CCOC(=O)Cc1c(C(F)(F)F)c2ccc(O)cc2oc1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.60
ALDH1A1 P00352 4/20 0.60
CASP1 P29466 4/20 0.60
CASP7 P55210 4/20 0.60
HSD17B10 Q99714 4/20 0.60
GLA P06280 4/20 0.60
GAA P10253 4/20 0.60
HPGD P15428 3/20 0.60
HSD17B3 P37058 6/20 0.58
ESR1 P03372 2/20 0.58
AR P10275 1/20 0.58
CYP2C9 P11712 1/20 0.56
LMNA P02545 3/20 0.55
MAPT P10636 2/20 0.55
THRB P10828 1/20 0.55
HTT P42858 1/20 0.55
ATM Q13315 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.54
JAK2 O60674 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5272845 0.87 CYP2C9 (0.76) KDM4EALDH1A1CASP1CASP7HSD17B10
SCHEMBL10955623 0.84 KDM4E (0.78) KDM4EALDH1A1CASP1CASP7HSD17B10
SCHEMBL14384569 0.83 CYP2C9 (0.70) KDM4EALDH1A1CASP1CASP7HSD17B10
SCHEMBL14111526 0.81 AKR1B1 (0.56) KDM4EALDH1A1CASP1CASP7HSD17B10
SCHEMBL10637081 0.76 HSD17B3 (0.69) KDM4EALDH1A1CASP1CASP7HSD17B10
SCHEMBL3136947 0.76 HSD17B3 (0.60) KDM4EALDH1A1CASP1CASP7HSD17B10
SCHEMBL2554744 0.75 KDM4E (1.00) KDM4EALDH1A1CASP1CASP7HSD17B10
SCHEMBL30406107 0.75 KDM4E (1.00) KDM4EALDH1A1CASP1CASP7HSD17B10
SCHEMBL5905798 0.75 CYP2C9 (0.79) KDM4EALDH1A1HSD17B10GAAHPGD
SCHEMBL4209634 0.73 KDM4E (0.76) KDM4EALDH1A1CASP1CASP7HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1119639-B1 7-ALKOXYCOUMARINS AS CYP2C9 SUBSTRATES SMITHKLINE BEECHAM PLC (GB) 2007-11-28 EP disclosed
US-6756209-B1 FOR TESTING FOR INHIBITORS OF THE ENZYME CYP2C9(CYTOCHROME P450) WHICH IS RESPONSIBLE FOR THE METABOLISM OF DRUGS SMITHKLINE BEECHAM P.L.C. (GB) 2004-06-29 US disclosed
EP-1119639-A1 7-ALKOXYCOUMARINS AS CYP2C9 SUBSTRATES SMITHKLINE BEECHAM PLC (GB) 2001-08-01 EP disclosed
WO-2000022159-A1 7-ALKOXYCOUMARINS AS CYP2C9 SUBSTRATES SMITHKLINE BEECHAM PLC (GB) 2000-04-20 WO disclosed